SEC Tracker
Get the app

Possible new enVVeno Medical shares

NVNODilution

Known so far: no new shares from the prospectus covers read · shelf not limited by the baby-shelf rule · not yet read: converts, ATM.

Shelf room

  • Room today not capped by the baby-shelf rule ($76.1M float, Jun 30, 2025)
How this is worked out

Shelf room on the S-3 of Mar 12, 2025: not limited by the baby-shelf rule, because the $76.1M public float stated as of Jun 30, 2025 is $75M or more. Sources: S-3/A Mar 12, 2025, effective Mar 14, 2025 · public float, as of Jun 30, 2025.

What could become new enVVeno Medical (NVNO) shares: warrants and options and RSUs, each with the 10-Q, 10-K, S-3 or 424B filing it comes from.

enVVeno Medical dilution ladder

Every source of new shares on record, from the filings that created it.

695K outstanding; up to 16.1M fully diluted, +2219%

  1. Outstandingas of Oct 27, 2026 (10-Q filed Oct 29) · share count on the cover page
    695K
  2. Warrants9.1M10-Q Oct 30, 2025 · securities left out of diluted EPS
    +9.1M
  3. Options and RSUs6.3M options10-Q Oct 30, 2025 · securities left out of diluted EPS
    +6.3M

Not stated in the filings we read: an ATM program, convertible notes.

Counts, sizes and prices as stated in each filing; the fully diluted count is arithmetic on them. Dollars become shares only at a price a filing states. Not advice.

Financing terms to know

None found in filings since Oct 30, 2025.

Each term is quoted from the exhibit it comes from; numbers are as stated in the filing. A flag describes a financing term. It is not investment advice.

Shares outstanding

695K

Feb 2025 to Oct 2026: from 501K to 695K. Adjusted for the 1-for-35 reverse split by Mar 24, 2026: each earlier count is divided by the ratio of every split after it.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.